Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus

J. Koch(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Per Sonne Holm(Innsbruck Medical University)
Nature Communications
August 10, 2022
Cited by 35


Related Papers